Evidence map›Paper›PMID 31159867›Full record

ArticleHuman genomics2019

IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients.

Lidiia Zhytnik, Katre Maasalu, Binh Ho Duy, Andrey Pashenko, Sergey Khmyzov, Ene Reimann, Ele Prans, Sulev Kõks, Aare Märtson

Open access · goldAbstract read
In one paragraph

Article in Human genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Lidiia ZhytnikDepartment of Traumatology and Orthopeadics, University of Tartu, Puusepa 8, 51014, Tartu, Estonia. Lidiia.Zhytnik@ut.ee.ORCID 0000-0003-4682-0402
Katre MaasaluDepartment of Traumatology and Orthopeadics, University of Tartu, Puusepa 8, 51014, Tartu, Estonia.
Binh Ho DuyHue University of Medicine and Pharmacy, Hue University, Hue, Vietnam.
Andrey PashenkoDepartment of Pediatric Orthopedics, Sytenko Institute of Spine and Joint Pathology, AMS Ukraine, Pushkinska 80, Kharkiv, 61024, Ukraine.
Sergey KhmyzovDepartment of Pediatric Orthopedics, Sytenko Institute of Spine and Joint Pathology, AMS Ukraine, Pushkinska 80, Kharkiv, 61024, Ukraine.
Ene ReimannCentre of Translational Medicine, University of Tartu, Ravila 14a, 50411, Tartu, Estonia.
Ele PransDepartment of Pathophysiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Sulev KõksPerron Institute for Neurological and Translational Science, QEII Medical Centre, Nedlands, WA, Australia.
Aare MärtsonDepartment of Traumatology and Orthopeadics, University of Tartu, Puusepa 8, 51014, Tartu, Estonia.
University of Tartu · EESytenko Institute of Spine and Joint Pathology of the National Academy of Medical Sciences of Ukraine · UATartu University Hospital · EEHue University · VNQueen Elizabeth II Medical Centre · AU

Funding

Estonian Ministry of Education and Research IUT20-46, DIOXMED, EVMEDH2020 ERA-chair grant 668989, project Transgeno
6 · The paper itself

Abstract

backgroundOsteogenesis imperfecta (OI) covers a spectrum of bone fragility disorders. OI is classified into five types; however, the genetic causes of OI might hide in pathogenic variants of 20 different genes. Often clinical OI types mimic each other. This sometimes makes it impossible to identify the OI type clinically, which can be a risk for patients. Up to 90% of OI types I-IV are caused by pathogenic variants in the COL1A1/2 genes. OI type V is caused by the c.-14C > T pathogenic variant in the 5'UTR of the IFITM5 gene and is characterized by hyperplastic callus formation and the ossification of interosseous membranes.

resultsIn the current study, we performed IFITM5 5'UTR region mutational analysis using Sanger sequencing on 90 patients who were negative for COL1A1/2 pathogenic variants. We also investigated the phenotypes of five patients with genetically confirmed OI type V. The proportion of OI type V patients in our cohort of all OI patients was 1.48%. In one family, there was a history of OI in at least three generations. Phenotype severity differed from mild to extremely severe among patients, but all patients harbored the same typical pathogenic variant. One patient had no visible symptoms of OI type V and was suspected to have had OI type IV previously. We also identified a case of extremely severe hyperplastic callus in a 15-year-old male, who has hearing loss and brittleness of teeth.

conclusionsOI type V is underlined with some unique clinical features; however, not all patients develop them. The phenotype spectrum might be even broader than previously suspected, including typical OI features: teeth brittleness, bluish sclera, hearing loss, long bones deformities, and joint laxity. We suggest that all patients negative for COL1A1/2 pathogenic variants be tested for the presence of an IFITM5 pathogenic variant, even if they are not expressing typical OI type V symptoms. Further studies on the pathological nature and hyperplastic callus formation mechanisms of OI type V are necessary.

Indexed as

5' Untranslated RegionsAdolescentAdultChildChild, PreschoolCollagen Type ICollagen Type I, alpha 1 ChainDNA Mutational AnalysisFemaleHumansMaleMembrane ProteinsMutationOsteogenesis ImperfectaPhenotypePolymorphism, Single Nucleotide5' Untranslated RegionsCOL1A2 protein, humanCollagen Type ICollagen Type I, alpha 1 ChainIFITM5 protein, humanMembrane ProteinsBone fragilityHyperplastic callusIFITM5Osteogenesis imperfectaType V

Identifiers

PMID31159867
PMCPMC6547447
OpenAlexW2948054766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.